mHealth Israel

Tokyo Growth Machine© March 23-26

Mon, Mar 23 · 2:00 AM IST

Sheraton Miyako Hotel, 1-1-50, Shirokanedai, Minato-ku, Tokyo 108-8640, Japan, Tokyo, JP

Tokyo Growth Machine©**, Powered by mHealth Israel**

Interview and approval required. This is for Series A / B (and beyond) biotech and medical device companies that have raised at least $10m with some traction in either the US or Israel. Time in Tokyo is exclusively dedicated to meetings with Japanese corporates and investors. To arrange an in-person interview (Jan 25-Feb 2), contact levi.shapiro@gmail.com or horigome.mihoko.0318@gmail.com

Application Deadline: Feb 1st
Interview Period: Jan 22-Feb 1 (Tel Aviv)
Eligibility: Series A / B Israeli biotech and medical device companies, with at least $10m raised in equity / grants
Program:
- Pre-visit: 4 online sessions focused on Japan Healthcare market
- Pre-visit: Israel Gathering
- Tokyo residence (March 23-26) meeting Japanese corporates, investors and government officials
Tokyo Schedule (March 23-26):
- 20 Japanese corporates (including at least 6 Pharmas)
- 15 Japan-based healthtech investors
- 3 relevant government agencies
Accommodations: 5 star Sheraton / Miyako. JPY 23,000 (double occupancy); JPY 21,000 (single occupancy

Background: Systematic program for ultra-high potential, market-ready, Series A / B Israeli founded biotech and medical device companies.

Why: Japan is the world #4 healthcare market. Unfortunately, Israel ranks #40 among countries exporting to Japan. The Tokyo Growth Machine© combines systematic preparation with a robust network of relationships and track record securing local partnerships.

Participating Companies: Executive leadership (Founder preferred) from 10 market-ready, Israeli Sereis A / B biotech and Medical Device companies with US or Israel market traction.

Online Sessions:
• Market Overview
• NHI Pricing & Reimbursement
• Regulatory Pathways & Market Access
• Provider Landscape & Care Delivery Models
• Pharmaceutical Market Dynamics
• MedTech & Diagnostics Market Overview
• Long‑Term Care & Elderly Care Market
• Commercial Strategy & Go‑to‑Market Models
• Competitive Landscape & Case Studies
• Working with Japanese Corporates
• Negotiation in a Japanese context

Methodology: Hybrid online / in-person; Combining theoretical frameworks with hands-on mentoring and business development.

• Online component (4 weeks)
• Weekly online workshops, supplemented with weekly mentoring.
• Israel meet-and=gree at the conclusion of the online program.
• Four day Tokyo residential experience, March 23-26
  - Optional guided tourism near Tokyo, March 21-22
• Japan Investors Round Robin, March 23
• Japan Corporate Round Robin, March 26

Mentors: 20 Tokyo-based mentors spanning finance, technology, investment, government and other key sectors. This group can provide valuable insights and introductions.

Past Results: This team has an unrivaled track record of bridging Israel / Japan and securing corporate partnerships on behalf of Israeli HealthTech companies.

Principal Partners, Japan:

• METI, the Japan Ministry of Economy, Trade and Industry
• FujiFilm (world leader in imaging and medical devices)
• Astellas (#2 Japanese pharma)
• Many, many other Japanese companies committed to participate

Participation Fee: $2500, excluding flight, hotel and travel expenses. Companies may also pay via equity options, but at higher exchange.

Team:
Gali Einav, PhD
• Co-Founder, Vetted VC Accelerator; General Partner, Vetted VC
• Program Head, Adelson School of Entrepreneurship, Reichman University
• Professor of Entrepreneurship, Yeshiva University
• Director, Digital Research, NBC ]Universal
• Advisory Board: Nielsen Innovate Fund; Yeshiva Univ. Innovation Lab
• MA, Hebrew University; PhD, Columbia University

Levi Shapiro
• Founder and Chair, mHealth Israel (12,000+ Israeli tech ]entrepreneurs)
• Board Member: 4 startups
• Veritas Ventures, Gemini Israel Partners
• Founder, 3 startups
• MNC Experience: IBM (Europe), Toyota (Japan)
• Tulane, Cornell, MIT (MBA)

Oren Kaplan
• Meitav (Israel’s largest investment house by AUM), Member of the Board and Founder, Meitav Global Markets
• Co-Founder / CEO, Sharing Alpha (Trip Advisor for Limited Partner investors; Acquired)
• Textbook author, “Behavioral Finance”
• Dealroom manager, Bank Otsar Hahayal and Bank Hapoalim
• UCL (Economics), Tel Aviv University / Wharton (MBA)

Amir Melnikov
• Head of R&D, International Program Manager, Directorate of Defense Research & Development
• Executive Officer, MEIMAD (110m NIS venture capital fund)
• R&D and Engineering Team Leader, Israel Defense Force
• Researcher, Superconductivity and Magnetic Measurements Institute, Bar Ilan University
• Bar Ilan (Physics), Reichman (MBA), Tokyo Institute of Technology (MA, Engineering)

Mihoko Horigome (MS, MBA)
• Senior Sales Executive, Bioscience Division, Thermo Fisher, Japan
• Masters of Biology / Neuroscience, Nagoya University
• MedTech MBA, Hebrew University

To Apply: Contact Levi.Shapiro@gmail.com; +972.52.3424.149 to schedule a Zoom discussion or f2f meeting in Tel Aviv (Jan 21-30).

Postponed (due to EU travel restrictions): EU MedTech Regulatory & GTM

Wed, Apr 15 · 9:00 AM IDT

Herzog law, 6 Yitzhak Sadeh, 1st Floor, Tel Aviv, IL

POSTPONED due to EU travel advisory. The speakers WILL come to Israel but are forced to delay this trip due to the EU travel advisory.

Three experts, coming from Glasgow, Stockholm and London: Europe MedTech Regulatory & Go-To-Market Workshop, with Edward Staunton, Fredrik Johansson and Mel Wallace..

Cut through the noise of EU MDR, IVDR, and market access challenges. Experts with decades of experience share their practical regulatory and GTM best practices. Venue is Herzog Towers, 6 Sadeh, TLV.

Key Sections:
• Breakdown of the EU regulatory landscape, including compliance
• Guidance on classification, documentation, timelines and BUDGET
• Hospital pilot structures that prove cost savings in real workflows
• Economic cases tailored to payer and hospital incentives

This hands-on workshop will help you avoid regulatory and Go-To-Market hurdles and make Europe a launchpad, instead of a bottleneck.

Title: Europe MedTech Regulatory & GTM Workshop, with Edward Staunton, Fredrik Johansson and Mel Wallace
Speakers: Edward Staunton, Director, Regulatory Affairs & Quality, Clinigen.
Fredrik Johansson, Director, Business Development, Commercial Strategy, Clinigen
Mel Wallace, Vice President, Clinical Supplies Management, Clinigen
Time: 9-11am (9:30 start)
Venue: Herzog Towers, 6 Sadeh, Tel Aviv
MC: Goel Jasper, FINN Partners
Agenda:
9:00-9:30 Registration and networking
9:30-9:35 Welcome Remarks, Goel Jasper
9:35-9:40 mHealth Israel Introductory Remarks
9:40-9:50 Introduction to Clinigen, Mel Wallace, VP, Clinical Supplies Management
9:50-10:25 EU MedTech Regulatory Workshop, led by Edward Staunton
10:25-10:50 EU MedTech Go-to-Market insights, Frederik Johanssen

See you at Herzog Towers, 6 Sadeh, TLV, for Europe MedTech Regulatory & GTM Workshop, with Edward Staunton, Fredrik Johansson and Mel Wallace.

Paid Event: Singapore Delegation, May 5-7 (Hospitals + Investors)

Tue, May 5 · 2:00 PM IDT

Sands Expo & Convention Center, 10 Bayfront Avenue, Singapore, SG

This is a paid event that requires approval from the organizers. Registering on the MEETUP site is not sufficient to secure particiaption. If interested in participating, please contact levi.shapiro@gmail.com or horigome.mihoko.0318@gmail.com by Feb 1.

May 5-7, Singapore: Investor meetings + HealthTechX Asia (see confirmed speakers in the photos)

Join mHealth Israel for a Singapore healthtech delegation, May 5-7, with two components:

• Singapore, May 5th: Half day meetings with local family offices and VC investors + half day with prominent corporates (targets include SingHealth, Olympus, Hoya...to be confirmed)
• Regional Hospitals, May 6-7: Pavilion at HealthTechX Asia. Each company has their own exhibition space, 10 companies total. Opportunitity to present. Some introductions arranged by the organizers and the Economic Attache. Venue: Sands Expo & Convention Centre, 10 Bayfront Avenue, Singapore

Some of the key themes and sessions at HealthTechX Asia include:
• AI for Clinical Decision Support & Workflow Automation
• Smart Hospitals & Digital Infrastructure Modernisation
• National Digital Health Policy & Data Governance
• Funding, Scaling & Value-Based Care Models
Confirmed Presenters:

• Colin Lim, CIO & CDO, Ministry of Health Singapore
• Charlene Liew, Director, AI Office, Changi General Hospital
• Christine Ng, Partner, Vertex Ventures

· Chien-Chang Lee - CIO, Ministry of Health and Welfare of Taiwan, Taiwan
· Dr.Ravi Sachdev - Chief Clinical Informatics Officer, Tan Tock Seng Hospital, Singapore

Evening activities planned for both May 5 and May 6.

Pavillion Layout: See photo section

Cost : $2,000 USD (Non-negotiable; Includes conference access; Excludes fliight and hotel)

Deadline: February 1

To reserve: levi.shapiro@gmail.com; WhatsApp: +972.52.3424.149